ArticleBMJ case reports2022

Durable remission with Bruton's tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma.

Binoy Yohannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.